Warren Buffett’s Berkshire Hathaway Cuts Stakes in 3 Drugmakers and GM, Adds to Kroger

3 years ago 378

Text size

Berkshire Hathaway pared its stakes successful 3 cause stocks— AbbVie, Bristol Myers Squibb, and Merck —and reduced its presumption successful General Motors during the 2nd quarter, according to its 13-F filing for the play released aft the marketplace adjacent connected Monday.

Berkshire (ticker: BRK.A and BRK.B) added to its involvement successful Kroger (KR) and somewhat trimmed its holding successful Chevron (CVX).

Overall, Berkshire CEO Warren Buffett and his concern lieutenants, Todd Combs and Ted Weschler, made fewer notable changes to Berkshire’s equity portfolio.

Berkshire sold 7 cardinal shares of General Motors (GM), cutting its involvement to 60 cardinal shares, present worthy $3.2 billion, portion adding 10.7 cardinal shares to its holding successful Kroger, which stood astatine 61.8 cardinal shares astatine the extremity of June.

Berkshire accumulated stakes successful AbbVie (ABBV), Bristol Myers (BMY), and Merck (MRK) during 2020 and sold them down successful the 2nd quarter. The AbbVie holding dropped by 2.4 cardinal shares, to 20.5 million; the Bristol Myers involvement declined by 4.7 cardinal shares, to 26.3 million, and the Merck presumption fell by astir half, falling 8.7 cardinal shares, to 9.2 million.

Berkshire eliminated a tiny holding of 643,000 shares of Biogen (BIIB) and added somewhat to its presumption successful Aon (AON), lifting the involvement by astir 300,000 shares to 4.4 million.

There were nary changes successful Berkshire’s 2 largest holdings, Apple (AAPL) and Bank of America (BAC). The Apple involvement held astatine 887 cardinal shares present worthy $134 cardinal portion the Bank of America holding stood astatine 1.01 cardinal shares present worthy $41 billion.

Berkshire’s holding successful Chevron was down astir 600,000 shares, to 23.1 million.

Write to Andrew Bary astatine andrew.bary@barrons.com

Read Entire Article